Market Research Reports, Inc. has announced the addition of “OpportunityAnalyzer: Chronic Lymphocytic Leukemia - Opportunity Analysis and Forecasts to 2018” research report to their offering. See more at- http://mrr.cm/ZWf

1. www.MarketResearchReports.com
Category : Pharma & Healthcare
All logos and Images mentioned on this slide belong to their respective owners.

2. www.MarketResearchReports.com
Introduction to Report
 Launch Date: June 30, 2014
 Number of Pages: 153
 Geography Coverage: Global
 Available Format: PDF
Price For Single User License: USD 5,995
Price For Site License: USD 11,990
Price For Global User License: USD 17,985
Delivery Time: Within 24 Hours (During Working
Days)

3. www.MarketResearchReports.com
About the Report
Chronic lymphocytic leukemia (CLL), the most
common form of adult leukemia, is caused by the
uncontrolled proliferation of B lymphocytes (a
type of white blood cell) in the bone marrow, blood
and lymphoid tissues.
This report focuses on the current treatment
landscape, unmet needs, pipeline and commercial
opportunity in the CLL market with coverage of
both the first-line and relapsed/refractory settings.
While the current standard of care consists of
chemoimmunotherapy, CLL disease management
is poised for dramatic changes, particularly in the
treatment of relapsed/refractory and elderly
patients, as four new drugs (Gazyva, Imbruvica,
idelalisib and IPI-145) will launch during the
forecast period.

4. www.MarketResearchReports.com
Scope:
Key countries covered: US, France, Germany,
Italy, Spain, and UK
Overview of CLL, including epidemiology,
etiology, pathophysiology, clinical staging,
symptoms, quality of life, and disease
management.
Topline CLL therapeutics market revenue from
2013-2018. Annual cost of therapy, and major
marketed and pipeline drug sales in this forecast
period are included.
Key topics covered include strategic competitor
assessment, market characterization, unmet
needs, R&D strategies, and clinical trial design for
the CLL market.

5. www.MarketResearchReports.com
Scope: Continues…
Pipeline analysis: comprehensive data split
across different phases, emerging novel trends
under development, synopses of innovative early-
stage projects, and detailed analysis of late-stage
pipeline drugs.
An interactive clinical and commercial analyzer
tool is available.
Analysis of the current and future market
competition in the 6MM CLL therapeutics market.
Insightful review of the key industry drivers,
restraints and challenges.
Each trend is independently researched to
provide qualitative analysis of its implications.

6. www.MarketResearchReports.com
Reasons to buy:
Develop and design your in-licensing and out-
licensing strategies through a review of pipeline
products and technologies, and by identifying the
companies with the most robust pipeline.
Develop business strategies by understanding
the trends shaping and driving the 6MM CLL
market.
Drive revenues by understanding the key trends,
innovative products and technologies, market
segments, and companies likely to impact the
6MM CLL therapeutics market in the future.
Formulate effective sales and marketing
strategies by understanding the competitive
landscape and by analysing the performance of
various competitors.

7. www.MarketResearchReports.com
Key Findings:
The CLL market, in the 6MM is forecasted to
rapidly increase from $1.4bn in 2013 to $3.3bn in
2018, at a CAGR of 18.8%. This growth will be
driven by the launch and adoption of four new
premium-priced drugs during the forecast period,
including Gazyva, Imbruvica, idelalisib and IPI-145.
Publisher expects there will be rapid uptake of
the new agents in the relapsed/refractory setting,
particularly in those patients who do not have a
good response to first-line treatment.
Among the new agents, Publisher expects
Imbruvica and idelalisib will dominate patient
share and will account for more than 60% of all
total sales in 2018 and drive 100% of total market
growth.

8. www.MarketResearchReports.com
Report Coverage
1. Introduction
2. Disease Overview
3. Disease Management
4. Epidemiology
5. Current Treatment Options
6. Unmet Needs Assessment and Oppportunity
Analysis
7. R&D Strategies
8. Pipeline Assessment
9. Pipeline Valuation Analysis
10.Appendix
For more details regarding Report coverage see the last slide
All logos and Images mentioned on this slide belong to their respective owners.

9. www.MarketResearchReports.com
Custom Research:
 Are you an industry professional, entrepreneur,
venture capitalist, investors and organization, then let
us know your specific research requirements. Our goal
is to cater to your requirements be it for a custom
market research project, syndicated research report on
a specific market or industry sector, newsletter creation,
case study development or anything else related to
marketing research.
For Any Customization Related query Visit IdeaCenter @
http://www.marketresearchreports.com/idea-center

10. www.MarketResearchReports.com
How To Buy This Report?
Visit following URL to see Table of Content and
purchase this publication:
http://mrr.cm/ZWf
About Market Research Reports, Inc.
Market Research Reports provides a customized set
of reports from reputed Publishers, built on the
intelligence available within organizations and
leverages on our motto of “Intelligence Redefined”.
Contact : Amitava Sen
Email : info@marketresearchreports.com
Phone: +1 302-703-7787 (USA) +91-8762746600 (India)